NW
Biological & Safety TestingCharacterization & Testing

Liquid Biopsy & cfDNA Analysis

By Ceres Nanosciences, Inc.

Improve detection sensitivity for oncology and precision medicine. Enhance recovery of cell-free DNA (cfDNA) and biomarkers from challenging matrices, including plasma, whole blood, and Streck BCT, ensuring superior results for sensitive downstream NGS and PCR analysis.